DanCann Pharma A/S (NGM:DANCAN)
Sweden
· Delayed Price · Currency is SEK · Price in DKK 1.200
-0.110 (-8.40%)
At close: May 9, 2025
DanCann Pharma Revenue
In the year 2024, DanCann Pharma had annual revenue of 7.37M DKK with 3.06% growth. DanCann Pharma had revenue of 959.00K in the quarter ending December 31, 2024, a decrease of -40.47%.
Revenue
7.37M DKK
Revenue Growth
+3.06%
P/S Ratio
0.62
Revenue / Employee
1.47M DKK
Employees
5
Market Cap
6.98M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 104.49B |
| Atlas Copco AB | 176.63B |
| AB Volvo | 517.43B |
| ASSA ABLOY AB | 152.90B |
| EQT AB | 30.39B |
| Skandinaviska Enskilda Banken AB | 79.55B |
| Swedbank AB | 73.90B |
| Sandvik AB | 123.18B |